Please login to the form below

Not currently logged in
Email:
Password:

Medivir appoints Actelion's Henric Juserius to senior commercial role

As executive vice president, commercial he will head up all the company's activities in the area

Medivir has appointed Actelion's Henric Juserius to head up its commercial activities and join its management team.

Juserius will move to the Swedish specialty pharma company in August from Actelion, where he was most recently commercial director for the Nordic region.

He has more than 20 years' experience in pharmaceutical marketing and sales, gained from companies such as Astra, GlaxoWellcome, Pfizer, Serono and Actelion.

Maris Hartmanis, Medivir's president and CEO, said: "I am very pleased to welcome Henric Juserius to Medivir as executive vice president, commercial.

“His extensive experience and broad expertise in marketing and sales of prescription drugs from both large and small pharmaceutical companies will be invaluable now that Medivir is approaching a market launch in the Nordic countries of its flagship product for hepatitis C, TMC435.”

The drug is a novel protease inhibitor in phase III clinical trials for hepatitis C that Medivir is developing in collaboration with Janssen Pharmaceuticals.

Meanwhile, the firm's first product, OTC cold sore treatment Xerese/Xerclear, is approved in Europe, where Medivir is launching it in partnership with GlaxoSmithKline.

15th May 2012

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...

Infographics